Safety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study

BACKGROUND/AIMS: The use of antiangiogenic agents (AAs) in cancer treatment has increased because they offer survival benefit in combination with cytotoxic chemotherapy. Given their potential to cause gastrointestinal (GI) perforation and bleeding, it is currently recommended that AAs be held for 28...

Descripción completa

Detalles Bibliográficos
Autores principales: Kachaamy, Toufic, Gupta, Digant, Edwin, Persis, Vashi, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417598/
https://www.ncbi.nlm.nih.gov/pubmed/28472195
http://dx.doi.org/10.1371/journal.pone.0176899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417598/
https://www.ncbi.nlm.nih.gov/pubmed/28472195
http://dx.doi.org/10.1371/journal.pone.0176899

Ejemplares similares